Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predicting Progression--ZAP-70 in CLL.

The New England journal of medicine - 26 Aug 2004

Hamblin Terry J

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunoglobulin Heavy Chains
Share to B-Lymphocytes
Share to Genes, Immunoglobulin
Share to Leukemia, Lymphocytic, Chronic, B-Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Protein-Tyrosine Kinases

Share to Receptors, Antigen, T-Cell

Share to T-Lymphocytes

Share to ZAP-70 Protein-Tyrosine Kinase

Source

Identifiers

PMID: 15329421
DOI: 10.1056/NEJMp048184

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predicting Progression--ZAP-70 in CLL.PMID 15329421Read ↗

Predicting treatment outcomes in CLL.Semantic proximity Read ↗

iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.Semantic proximity Read ↗

Clinical implications of ZAP-70 expressionin chronic lymphocytic leukemia.Semantic proximity Read ↗

Molecular profiling in CLL.Semantic proximity Read ↗

Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia.Semantic proximity Read ↗

The use of molecular markers in selecting therapy for CLL.Semantic proximity Read ↗

Optimizing frontline therapy of CLL based on clinical and biological factors.Semantic proximity Read ↗

Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progressionSemantic proximity Read ↗

Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment.Semantic proximity Read ↗

Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.Semantic proximity Read ↗

Prognostic markers in chronic lymphocytic leukemia: a comprehensive review.Semantic proximity Read ↗

Using prognostic models in CLL to personalize approach to clinical care: Are we there yet?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.